Finally, different approaches aimed at reducing HuR expression in cancer cells have been proposed and include the delivery of specific siRNAs through various carriers, including nanoparticle-based delivery, liposome-based nanoparticles, poly amidoamine nanoparticles, or DNA dendrimer nanocarriers [193]. Here, ELAVL1 is linked to cancer.